• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Directories » FDA Approved Drugs » Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel)

AND
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel)

  • Profile

Profile

Contact Information

Contact: Bausch Health
Website: https://www.bauschhealth.com/Portals/25/Pdf/PI/Benzamycin-PI.pdf

Currently Enrolling Trials

    Show More

    General Information

    Benzamycin is a combination of two active ingredients, benzoyl peroxide and erythromycin, which has proven effective in stopping acne-causing bacteria and reducing acne infection. 

    Benzamycin is specifically indicated for the topical treatment of acne vulgaris.

    Benzamycin is supplied as a gel for topical administration. The gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry.

    Mechanism of Action

    Benzamycin is a combination of two active ingredients, benzoyl peroxide and erythromycin, which has proven effective in stopping acne-causing bacteria and reducing acne infection. Erythromycin is an antibiotic produced from a strain of Saccharopolyspora erythraea, whereas benzoyl peroxide is an antibacterial and keratolytic agent (causes the break down of keratin).

    Side Effects

    Adverse effects associated with the use of Benzamycin Topical Gel may include, but are not limited to, the following:

    • Dryness
    • Urticarial reaction (hives, itching)
    • Peeling
    • Burning sensation
    • Inflammation of the face, eyes, and nose
    • Skin discoloration
    • Oiliness
    • Tenderness of the skin

    Clinical Trial Results

    No clinical trial data is available on company site or drug label.

    Approval Date: 2000-11-01
    Company Name: Bausch Health
    Back to Listings

    Upcoming Events

    • 16Feb

      Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

    • 21May

      WCG MAGI Clinical Research Conference – 2023 East

    Featured Products

    • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

      Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    Featured Stories

    • SurveywBlueBackground-360x240.png

      Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

    • TrendsInsights2023-360x240.png

      WCG Clinical Research Trends and Insights for 2023, Part Two

    • TimeMoneyEffort-360x240.png

      Time is Money and So Is Effort, Budgeting Experts Say

    • TrendsInsights2023A-360x240.png

      WCG Clinical Research Trends and Insights for 2023, Part Three

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 617.948.5100 – Toll free 866.219.3440

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing